Evropska unija - slovenščina - EMA (European Medicines Agency)

stada arzneimittel ag - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - oyavas in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. oyavas in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. za nadaljnje informacije o statusu receptorja človeškega epidermičnega rastnega faktorja 2 (her2) glejte poglavje 5. oyavas in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with oyavas in combination with capecitabine. za nadaljnje informacije o statusu her2 glejte poglavje 5. oyavas, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. oyavas, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5. oyavas in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. oyavas, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. oyavas, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents. oyavas, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents (see section 5. oyavas, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

berlin-chemie ag - enalapril; hidroklorotiazid - tableta - enalapril 7,65 mg / 1 tableta  hidroklorotiazid25 mg / 1 tableta; hidroklorotiazid 25 mg / 1 tableta - enalapril in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta  perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta  perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin; perindopril - tableta - amlodipin 10 mg / 1 tableta  perindopril6,68 mg / 1 tableta; perindopril 6,68 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin; perindopril - tableta - amlodipin 5 mg / 1 tableta  perindopril6,68 mg / 1 tableta; perindopril 6,68 mg / 1 tableta - perindopril in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

stada arzneimittel ag - amlodipin, valsartan - filmsko obložena tableta - amlodipin 10 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in amlodipin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

berlin-chemie ag - enalapril; hidroklorotiazid - tableta - enalapril 7,65 mg / 1 tableta  hidroklorotiazid25 mg / 1 tableta; hidroklorotiazid 25 mg / 1 tableta - enalapril in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

menarini international o.l.s.a. - hidroklorotiazid; medoksomilolmesartanat - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta  medoksomilolmesartanat20 mg / 1 tableta; medoksomilolmesartanat 20 mg / 1 tableta - medoksomilolmesartanat in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz gmbh - ramipril - tableta - ramipril 5 mg / 1 tableta - ramipril